drugset / Trial / NCT05355610

Vestibular Rehabilitation With Intratympanic Drug Therapy in Meniere's Disease

NCT05355610

Unknown 93 enrolled Combined Military Hospital Quetta
NaSingle-groupOpen-labelTreatment

Summary

Intractable symptoms of Meniere's disease will be treated with intratympanic steroids. At the same time intratympanic dexamethasone will be used to rescue hearing

Timeline

Start
2021-04-01
Primary completion
2022-04-22
Completion
2022-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule Other
Subject Gentamicin Small molecule Other

Indications